TGFBR1 and endometrium adenocarcinoma: (38) introduced and analyzed a mouse model with conditional inactivation of activin receptor-like kinase 5 (ALK5) in the uterus using progesterone receptor—the mice developed endometrial adenocarcinoma with metastases to the lungs.